Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
N/A
14 Years
85 Years
14 Years
85 Years
Open (Enrolling)
Both
Colon Cancer
Both
Colon Cancer
Trial Information
Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
Inclusion Criteria:
- Patients with Adjuvant Colon Cancer
Exclusion Criteria:
- Patients with diagnosis other than Colon Cancer.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Al Jubran, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
KFSH & RC
Authority:
United States: Institutional Review Board
Study ID:
RAC# 2071-027
NCT ID:
NCT01310972
Start Date:
September 2007
Completion Date:
Related Keywords:
- Colon Cancer
- Adjuvant Colon Cancer
- Colonic Neoplasms
Name | Location |
|---|
